NCT04104672
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04104672
Title A Study to Evaluate the Safety and Tolerability of AB680 in Participants With Gastrointestinal Malignancies (ARC-8)
Acronym ARC-8
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Arcus Biosciences, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
The Angeles Clinic Los Angeles California 90025 United States Details
UCLA Hematology Oncology Santa Monica California 90404 United States Details
Yale Cancer Center New Haven Connecticut 06520 United States Details
BRCR Global Plantation Florida 33322 United States Details
Washington University School of Medicine - Siteman Cancer Center St Louis Missouri 63110 United States Details
NYU Cancer Institute New York New York 10016 United States Details
Columbia University New York New York 10032 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Stephenson Cancer Center Oklahoma City Oklahoma 73104 United States Details
University of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
Thomas Jefferson University Hospital Philadelphia Pennsylvania 19107 United States Details
UPMC Hillman Cancer Center Pittsburgh Pennsylvania 15232 United States Details
Sarah Canon Research Institute Nashville Tennessee 37203 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
START San Antonio San Antonio Texas 78229 United States Details
UW Health - UW Carbone Cancer Center - Medical Oncology Clinic Madison Wisconsin 53792 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field